Dizlin Prescription drugs revealed knowledge from a pharmacokinetic examine (PK) (IPO-001) with Infudopa SubC (DIZ102) and Infudopa IntraV (DIZ101) in Neurology

Gothenburg, Sweden, September 7, 2022 /prnewswire/- Dizlin Prescription drugs AB, a research-based drug improvement firm specializing in ailments of the central nervous system (CNS), introduced that it has revealed an article in Neurology┬« from the American Academy of Neurology┬«, detailing the corporate’s IPO- The information is described. 001 Pharmacokinetic cross-over examine. In a pharmacokinetic cross-over … Read more